Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer Stage IA”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Testing effectiveness (Phase 2)Study completedNCT00513877
What this trial is testing

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Cancer Trials Ireland 33
Not applicableLooking for participantsNCT06503744
What this trial is testing

Transthoracic vs Transbronchial Ablation for Lung Cancer

Who this might be right for
Lung Cancer Stage IA
Shanghai Chest Hospital 110
Testing effectiveness (Phase 2)Study completedNCT00188617
What this trial is testing

Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC

Who this might be right for
LUNG CANCER
University Health Network, Toronto 35
Not applicableStudy completedNCT00450281
What this trial is testing

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 981
Large-scale testing (Phase 3)Study completedNCT00499330
What this trial is testing

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 701
Early research (Phase 1)Study completedNCT00254384
What this trial is testing

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02581787
What this trial is testing

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma
Maximilian Diehn 28
Not applicableUnknownNCT02288026
What this trial is testing

Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-small Cell Lung CancerAdenocarcinoma of the LungSquamous Cell Lung Cancer
Capital Medical University 630
Large-scale testing (Phase 3)UnknownNCT02481661
What this trial is testing

Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 610
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT04183218
What this trial is testing

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC V8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC V8Clinical Stage I Esophageal Adenocarcinoma AJCC V8+53 more
Mayo Clinic 24
Early research (Phase 1)Ended earlyNCT00856427
What this trial is testing

Implantation of Markers for the Radiotherapy of Lung Cancer Patients

Who this might be right for
Lung Cancer
Virginia Commonwealth University 6
Not applicableActive Not RecruitingNCT03066297
What this trial is testing

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

Who this might be right for
Stage IA Non-small Cell Lung Cancer
Samsung Medical Center 1,018
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03366766
What this trial is testing

Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Non-Squamous Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung Carcinoma+5 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 14
Not applicableStudy completedNCT01741636
What this trial is testing

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

Who this might be right for
Stage I Colon CancerStage I Rectal CancerStage IA Non-small Cell Lung Cancer+17 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01342770
What this trial is testing

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT01018147
What this trial is testing

4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition

Who this might be right for
Lung Cancer
Virginia Commonwealth University 22
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT03433469
What this trial is testing

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Who this might be right for
Stage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung CancerStage IB Non-Small Cell Lung Cancer+4 more
University of California, San Francisco 27
Load More Results